|
1
|
Bertrand FE, Angus CW, Partis WJ and
Sigounas G: Developmental pathways in colon cancer: crosstalk
between WNT, BMP, Hedgehog and Notch. Cell Cycle. 11:4344–4351.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar
|
|
3
|
Kinzler KW and Vogelstein B: Lessons from
hereditary colorectal cancer. Cell. 87:159–170. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vogelstein B, Papadopoulos N, Velculescu
VE, Zhou S, Diaz LA Jr and Kinzler KW: Cancer genome landscapes.
Science. 339:1546–1558. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kinzler KW, Nilbert MC, Su LK, et al:
Identification of FAP locus genes from chromosome 5q21. Science.
253:661–665. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chan TL, Zhao W, Leung SY and Yuen ST:
BRAF and KRAS mutations in colorectal hyperplastic
polyps and serrated adenomas. Cancer Res. 63:4878–4881.
2003.PubMed/NCBI
|
|
7
|
Hardwick JC, Kodach LL, Offerhaus GJ and
van den Brink GR: Bone morphogenetic protein signalling in
colorectal cancer. Nat Rev Cancer. 8:806–812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Massague J: TGF-beta signal transduction.
Annu Rev Biochem. 67:753–791. 1998. View Article : Google Scholar
|
|
9
|
Massague J: How cells read TGF-beta
signals. Nat Rev Mol Cell Biol. 1:169–178. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thiagalingam S, Lengauer C, Leach FS, et
al: Evaluation of candidate tumour suppressor genes on chromosome
18 in colorectal cancers. Nat Genet. 13:343–346. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Howe JR, Bair JL, Sayed MG, et al:
Germline mutations of the gene encoding bone morphogenetic protein
receptor 1A in juvenile polyposis. Nat Genet. 28:184–187. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Howe JR, Roth S, Ringold JC, et al:
Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science.
280:1086–1088. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Howe JR, Sayed MG, Ahmed AF, et al: The
prevalence of MADH4 and BMPR1A mutations in juvenile
polyposis and absence of BMPR2, BMPR1B, and ACVR1
mutations. J Med Genet. 41:484–491. 2004.PubMed/NCBI
|
|
14
|
Sayed MG, Ahmed AF, Ringold JR, et al:
Germline SMAD4 or BMPR1A mutations and phenotype of juvenile
polyposis. Ann Surg Oncol. 9:901–906. 2002.PubMed/NCBI
|
|
15
|
Haramis AP, Begthel H, van den Born M, et
al: De novo crypt formation and juvenile polyposis on BMP
inhibition in mouse intestine. Science. 303:1684–1686. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hardwick JC, Van Den Brink GR, Bleuming
SA, et al: Bone morphogenetic protein 2 is expressed by, and acts
upon, mature epithelial cells in the colon. Gastroenterology.
126:111–121. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Loh K, Chia JA, Greco S, et al: Bone
morphogenic protein 3 inactivation is an early and frequent event
in colorectal cancer development. Genes Chromosomes Cancer.
47:449–460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Beck SE, Jung BH, Fiorino A, et al: Bone
morphogenetic protein signaling and growth suppression in colon
cancer. Am J Physiol Gastrointest Liver Physiol. 291:G135–G145.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deng H, Makizumi R, Ravikumar TS, Dong H,
Yang W and Yang WL: Bone morphogenetic protein-4 is overexpressed
in colonic adenocarcinomas and promotes migration and invasion of
HCT116 cells. Exp Cell Res. 313:1033–1044. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Motoyama K, Tanaka F, Kosaka Y, et al:
Clinical significance of BMP7 in human colorectal cancer. Ann Surg
Oncol. 15:1530–1537. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lorente-Trigos A, Varnat F, Melotti A and
Ruiz i Altaba A: BMP signaling promotes the growth of primary human
colon carcinomas in vivo. J Mol Cell Biol. 2:318–332. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo X, Chen J, Song WX, et al: Osteogenic
BMPs promote tumor growth of human osteosarcomas that harbor
differentiation defects. Lab Invest. 88:1264–1277. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang N, Song WX, Luo J, et al:
BMP-9-induced osteogenic differentiation of mesenchymal progenitors
requires functional canonical Wnt/beta-catenin signaling. J Cell
Mol Med. 13:2448–2464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao Y, Huang E, Zhang H, et al: Crosstalk
between Wnt/β-catenin and estrogen receptor signaling
synergistically promotes osteogenic differentiation of mesenchymal
progenitor cells. PloS One. 8:e824362013.
|
|
25
|
Kong Y, Zhang H, Chen X, et al:
Destabilization of heterologous proteins mediated by the GSK3β
phosphorylation domain of the β-catenin protein. Cell Physiol
Biochem. 32:1187–1199. 2013.PubMed/NCBI
|
|
26
|
Zhang W, Zhang H, Wang N, et al:
Modulation of β-catenin signaling by the inhibitors of MAP kinase,
tyrosine kinase, and PI3-kinase pathways. Int J Med Sci.
10:1888–1898. 2013.
|
|
27
|
Chen X, Luther G, Zhang W, et al: The E–F
hand calcium-binding protein S100A4 regulates the proliferation,
survival and differentiation potential of human osteosarcoma Cells.
Cell Physiol Biochem. 32:1083–1096. 2013.
|
|
28
|
Cheng H, Jiang W, Phillips FM, et al:
Osteogenic activity of the fourteen types of human bone
morphogenetic proteins (BMPs. J Bone Joint Surg Am. 85-A:1544–1552.
2003.PubMed/NCBI
|
|
29
|
He TC, Zhou S, da Costa LT, Yu J, Kinzler
KW and Vogelstein B: A simplified system for generating recombinant
adenoviruses. Proc Natl Acad Sci USA. 95:2509–2514. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kang Q, Song WX, Luo Q, et al: A
comprehensive analysis of the dual roles of BMPs in regulating
adipogenic and osteogenic differentiation of mesenchymal progenitor
cells. Stem Cells Dev. 18:545–559. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kang Q, Sun MH, Cheng H, et al:
Characterization of the distinct orthotopic bone-forming activity
of 14 BMPs using recombinant adenovirus-mediated gene delivery.
Gene Ther. 11:1312–1320. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luo J, Deng ZL, Luo X, et al: A protocol
for rapid generation of recombinant adenoviruses using the AdEasy
system. Nat Protoc. 2:1236–1247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Luu HH, Kang Q, Park JK, et al: An
orthotopic model of human osteosarcoma growth and spontaneous
pulmonary metastasis. Clin Exp Metastasis. 22:319–329. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Luu HH, Zhou L, Haydon RC, et al:
Increased expression of S100A6 is associated with decreased
metastasis and inhibition of cell migration and anchorage
independent growth in human osteosarcoma. Cancer Lett. 229:135–148.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
He BC, Gao JL, Luo X, et al: Ginsenoside
Rg3 inhibits colorectal tumor growth through the down-regulation of
Wnt/β-catenin signaling. Int J Oncol. 38:437–445. 2011.PubMed/NCBI
|
|
36
|
He BC, Gao JL, Zhang BQ, et al:
Tetrandrine inhibits Wnt/β-catenin signaling and suppresses tumor
growth of human colorectal cancer. Mol Pharmacol. 79:211–219.
2011.
|
|
37
|
Su Y, Luo X, He BC, et al: Establishment
and characterization of a new highly metastatic human osteosarcoma
cell line. Clin Exp Metastasis. 26:599–610. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Su Y, Wagner ER, Luo Q, et al:
Insulin-like growth factor binding protein 5 suppresses tumor
growth and metastasis of human osteosarcoma. Oncogene.
30:3907–3917. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang J, Zhang H, Zhang W, et al: Bone
morphogenetic protein-9 (BMP9) effectively induces
osteo/odontoblastic differentiation of the reversibly immortalized
stem cells of dental apical papilla. Stem Cells Dev. Mar
21–2014.(Epub ahead of print).
|
|
40
|
Luo Q, Kang Q, Si W, et al: Connective
tissue growth factor (CTGF) is regulated by Wnt and bone
morphogenetic proteins signaling in osteoblast differentiation of
mesenchymal stem cells. J Biol Chem. 279:55958–55968. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Luther GA, Lamplot J, Chen X, et al:
IGFBP5 domains exert distinct inhibitory effects on the
tumorigenicity and metastasis of human osteosarcoma. Cancer Lett.
336:222–230. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
He BC, Chen L, Zuo GW, et al: Synergistic
antitumor effect of the activated PPARgamma and retinoid receptors
on human osteosarcoma. Clin Cancer Res. 16:2235–2245. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sharff KA, Song WX, Luo X, et al: Hey1
basic helix-loop-helix protein plays an important role in mediating
BMP9-induced osteogenic differentiation of mesenchymal progenitor
cells. J Biol Chem. 284:649–659. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chen L, Jiang W, Huang J, et al:
Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced
osteogenic differentiation and bone formation. J Bone Miner Res.
25:2447–2459. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang W, Deng ZL, Chen L, et al: Retinoic
acids potentiate BMP9-induced osteogenic differentiation of
mesenchymal progenitor cells. PloS One. 5:e119172010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Luo J, Tang M, Huang J, et al: TGFbeta/BMP
type I receptors ALK1 and ALK2 are essential for BMP9-induced
osteogenic signaling in mesenchymal stem cells. J Biol Chem.
285:29588–29598. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Slattery ML, Lundgreen A, Herrick JS,
Wolff RK and Caan BJ: Genetic variation in the transforming growth
factor-β signaling pathway and survival after diagnosis with colon
and rectal cancer. Cancer. 117:4175–4183. 2011.
|
|
48
|
Slattery ML, Lundgreen A, Herrick JS, et
al: Genetic variation in bone morphogenetic protein and colon and
rectal cancer. Int J Cancer. 130:653–664. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xiang L, Wang S, Jin X, Duan W, Ding X and
Zheng C: Expression of BMP2, TLR3, TLR4 and COX2 in colorectal
polyps, adenoma and adenocarcinoma. Mol Med Rep. 6:973–976.
2012.PubMed/NCBI
|
|
50
|
Kodach LL, Jacobs RJ, Voorneveld PW, et
al: Statins augment the chemosensitivity of colorectal cancer cells
inducing epigenetic reprogramming and reducing colorectal cancer
cell ‘stemness’ via the bone morphogenetic protein pathway. Gut.
60:1544–1553. 2011.PubMed/NCBI
|
|
51
|
Beck SE, Jung BH, Del Rosario E, Gomez J
and Carethers JM: BMP-induced growth suppression in colon cancer
cells is mediated by p21WAF1stabilization and modulated
by RAS/ERK. Cell Signal. 19:1465–1472. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kang MH, Kang HN, Kim JL, Kim JS, Oh SC
and Yoo YA: Inhibition of PI3 kinase/Akt pathway is required for
BMP2-induced EMT and invasion. Oncol Rep. 22:525–534.
2009.PubMed/NCBI
|
|
53
|
Wu WK, Sung JJ, Wu YC, Li ZJ, Yu L and Cho
CH: Bone morphogenetic protein signalling is required for the
anti-mitogenic effect of the proteasome inhibitor MG-132 on colon
cancer cells. Br J Pharmacol. 154:632–638. 2008. View Article : Google Scholar : PubMed/NCBI
|
